Form 483

Sanofi Winthrop Industrie Form 483, 2012-09-18

FDA issued a Form 483 to Sanofi Winthrop Industrie on 2012-09-18 with 5 public-safe observations.

483· Form 483 issued5 observations

Sanofi Winthrop Industrie · Maisons Alfort, France · Issued September 18, 2012

Overview

  • 5 public-safe observations are available for this inspection.
  • 4 structured CFR citations are represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

18 Sep 2012
21 CFR 211.42(c)

Defined areas of adequate size for operations

Cited by Ramon E Martinez

18 Sep 2012
21 CFR 211.67(a)

Cleaning / Sanitizing / Maintenance

Cited by Ramon E Martinez

18 Sep 2012
21 CFR 211.113(b)

Procedures for sterile drug products

Cited by Ramon E Martinez

18 Sep 2012
21 CFR 211.113(b)

Validation lacking for sterile drug products

Cited by Ramon E Martinez

18 Sep 2012
21 CFR 211.192

Investigations of discrepancies, failures

Cited by Ramon E Martinez

Inspected site

SWSanofi Winthrop IndustrieMaisons Alfort, France

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.113(b)Cited across public-safe Form 483 observations2x
21 CFR 211.192Cited across public-safe Form 483 observations1x
21 CFR 211.42(c)Cited across public-safe Form 483 observations1x
21 CFR 211.67(a)Cited across public-safe Form 483 observations1x

Full 483 report

Get the verbatim text of all 5 observations

Every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere